ENvue Medical, Inc.
FEED· OTC
Released Nov 16, 2020, after the close
10-Q filed Nov 16, 2020, 47 days after period end · 0001493152-20-021695
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $150.00K | $101.00K | $54.00K | $65.00K |
| Net Income | -$922.00K | -$815.00K | -$1.34M | -$1.60M |
| EPS Diluted |
ENvue Medical, Inc. · CIK 1326706 · Engraved from SEC EDGAR
| -$0.10 |
| -$0.12 |
| -$0.21 |
| -$0.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.